Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „does“
Suchtreffer
Begriffe & Kennungen
Gazyvaro · 4.8 · The population pharmacokinetic analysis (n = 196) of Gazyvaro showed that creatinine clearance does not affect
Eintrag öffnenHalaven · 4.5 · Eribulin does not inhibit the CYP enzymes CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6 or 2E1 at relevant clinical concent
Eintrag öffnenHycamtin · 4.5 · Topotecan does not inhibit human P450 enzymes (see section 5.2). In a population study using the intravenous r
Eintrag öffnenHycamtin · 4.5 · Topotecan does not inhibit human P450 enzymes (see section 5.2). In a population study using the intravenous r
Eintrag öffnenIasibon · 4.5 · Metabolic interactions are not considered likely, since ibandronic acid does not inhibit the major human hepat
Eintrag öffnenIdefirix · 4.5 · Imlifidase does not degrade equine anti-thymocyte globulin and no time interval between administrations needs
Eintrag öffnenImidoester
Eintrag öffnenIncresync · 4.5 · In vitro studies suggest that alogliptin does not inhibit nor induce CYP 450 isoforms at concentrations achiev
Eintrag öffnenInlyta · 4.5 · In vitro studies in human hepatocytes also indicated that axitinib does not induce CYP1A1, CYP1A2, or CYP3A4/5
Eintrag öffnenInlyta · 4.5 · In vitro studies of CYP and UGT inhibition and induction In vitro studies indicated that axitinib does not inh
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIvemend · 4.5 · Fosaprepitant 150 mg, given as a single dose, is a weak inhibitor of CYP3A4. Fosaprepitant does not seem to in
Eintrag öffnenJanumet · 4.5 · 7 In vitro data suggest that sitagliptin does not inhibit nor induce CYP450 isoenzymes. In clinical studies, s
Eintrag öffnenJanuvia · 4.5 · In vitro data suggest that sitagliptin does not inhibit nor induce CYP450 isoenzymes. In clinical studies, sit
Eintrag öffnenJardiance · 4.5 · Based on in vitro studies, empagliflozin does not inhibit, inactivate, or induce CYP450 isoforms. Empagliflozi
Eintrag öffnenJardiance · 4.5 · Empagliflozin does not inhibit P-gp at therapeutic doses. Based on in vitro studies, empagliflozin is consider
Eintrag öffnenJardiance · 4.5 · Empagliflozin does not inhibit human uptake transporters such as OAT3, OATP1B1, and OATP1B3 in vitro at clinic
Eintrag öffnen